Bristol-Myers Squibb Co
General ticker "BMY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $117.6B
Bristol-Myers Squibb Co follows the US Stock Market performance with the rate: 20.3%.
Estimated limits based on current volatility of 1.3%: low 56.29$, high 57.73$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-10-04, amount 0.60$ (Y4.17%)
- US accounted for 70.1% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [32.96$, 54.33$]
- 2024-12-30 to 2025-12-30 estimated range: [29.97$, 50.08$]
Financial Metrics affecting the BMY estimates:
- Positive: Non-GAAP EPS, $ of 7.50 > 2.29
- Positive: Operating cash flow per share per price, % of 13.25 > 12.76
- Positive: Operating profit margin, % of 36.88 > 19.51
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
Short-term BMY quotes
Long-term BMY plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $47,105.00MM | $45,583.00MM | $45,006.00MM |
| Operating Expenses | $39,007.00MM | $37,870.00MM | $27,764.00MM |
| Operating Income | $8,098.00MM | $7,713.00MM | $17,242.00MM |
| Non-Operating Income | $0.00MM | $0.00MM | $-8,802.00MM |
| Interest Expense | $1,334.00MM | $1,232.00MM | $1,166.00MM |
| R&D Expense | $10,195.00MM | $9,509.00MM | $9,299.00MM |
| Income(Loss) | $8,098.00MM | $7,713.00MM | $8,440.00MM |
| Taxes | $1,084.00MM | $1,368.00MM | $400.00MM |
| Profit(Loss) | $7,014.00MM | $6,345.00MM | $8,040.00MM |
| Stockholders Equity | $35,946.00MM | $31,061.00MM | $29,430.00MM |
| Inventory | $2,095.00MM | $2,339.00MM | $2,662.00MM |
| Assets | $109,314.00MM | $96,820.00MM | $95,159.00MM |
| Operating Cash Flow | $16,207.00MM | $13,066.00MM | $13,860.00MM |
| Capital expenditure | $973.00MM | $1,118.00MM | $1,209.00MM |
| Investing Cash Flow | $-538.00MM | $-1,062.00MM | $-2,295.00MM |
| Financing Cash Flow | $-16,224.00MM | $-16,962.00MM | $-9,416.00MM |
| Earnings Per Share* | $3.15 | $2.97 | $3.88 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.